MIV Therapeutics Inc. (MIVT) Featured in Cardiovascular Business News
10/24/2008 8:06:44 AM
More...
|
MIV Therapeutics Inc. (MIVT) Featured on Front Page of Medical Device Daily
10/23/2008 8:24:35 AM
More...
|
Update: JACC Intervention Publishes MIV Therapeutics Inc. (MIVT)'s VESTASYNC I Trial Preliminary Results
10/21/2008 8:23:04 AM
More...
|
MIV Therapeutics Inc. (MIVT) Announces Participation at TCT 2008 in Washington, D.C.
10/9/2008 12:45:29 PM
More...
|
MIV Therapeutics Inc. (MIVT) CEO, Dr. Mark Landy To Be Featured as Panelist at Medical Design & Manufacturing Minneapolis Conference
9/18/2008 9:56:28 AM
More...
|
MIV Therapeutics Inc. (MIVT) VESTAsync™ Drug-Eluting Stent Trials Progress
9/15/2008 9:54:22 AM
More...
|
MIV Therapeutics Inc. (MIVT) Announces Exchange Offer for Reg. S Shareholders in Europe
8/15/2008 8:48:30 AM
More...
|
MIV Therapeutics Inc. (MIVT) Announces Excellent Safety and Efficacy of VESTAsync(TM) Polymer-Free Drug-Eluting Stent at 12-Month Clinical Follow Up
8/5/2008 6:36:55 AM
More...
|
MIV Therapeutics Inc. (MIVT) to Present at the BMO Capital Markets Focus On Healthcare Conference
7/30/2008 9:59:13 AM
More...
|
MIV Therapeutics Inc. (MIVT) Provides Update on Its Next-Generation, Ultra-Thin Protea(TM) Stent Platform
7/16/2008 6:29:59 AM
More...
|
|